Trends in radiotherapy inpatient admissions in Germany: a population-based study over a 10-year period

被引:5
作者
Medenwald, Daniel [1 ]
Fietkau, Rainer [2 ]
Klautke, Gunther [3 ]
Langer, Susan [1 ]
Wuerschmidt, Florian [4 ]
Vordermark, Dirk [1 ]
机构
[1] Univ Hosp Halle Saale, Dept Radiat Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany
[2] Friedrich Alexander Univ Erlangen Nurnberg, Dept Radiat Oncol, Erlangen, Germany
[3] Chemnitz Hosp, Dept Radiat Oncol, Chemnitz, Germany
[4] Radiol Alliance, Hamburg, Germany
关键词
Inpatient cases; Radiotherapy departments; DRG data; Germany; Non-radiotherapy departments; PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL; CANCER; EUROPE; INFRASTRUCTURE; CHEMOTHERAPY; RADIATION; CARE;
D O I
10.1007/s00066-021-01829-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective With the increasing complexity of oncological therapy, the number of inpatient admissions to radiotherapy and non-radiotherapy departments might have changed. In this study, we aim to quantify the number of inpatient cases and the number of radiotherapy fractions delivered under inpatient conditions in radiotherapy and non-radiotherapy departments. Methods The analysis is founded on data of all hospitalized cases in Germany based on Diagnosis-Related Group Statistics (G-DRG Statistics, delivered by the Research Data Centers of the Federal Statistical Office). The dataset includes information on the main diagnosis of cases (rather than patients) and the performed procedures during hospitalization based on claims of reimbursement. We used linear regression models to analyze temporal trends. The considered data encompass the period from 2008 to 2017. Results Overall, the number of patients treated with radiotherapy as inpatients remained constant between 2008 (N = 90,952) and 2017 (N = 88,998). Starting in January 2008, 48.9% of 4000 monthly cases received their treatment solely in a radiation oncology department. This figure decreased to 43.7% of 2971 monthly cases in October 2017. We found a stepwise decrease between December 2011 and January 2012 amounting to 4.3%. Fractions received in radiotherapy departments decreased slightly by 29.3 (95% CI: 14.0-44.5) fractions per month. The number of days hospitalized in radiotherapy departments decreased by 83.4 (95% CI: 59.7, 107.0) days per month, starting from a total of 64,842 days in January 2008 to 41,254 days in 2017. Days per case decreased from 16.2 in January 2008 to 13.9 days in October 2017. Conclusion Our data give evidence to the notion that radiotherapy remains a discipline with an important inpatient component. Respecting reimbursement measures and despite older patients with more comorbidities, radiotherapy institutions could sustain a constant number of cases with limited temporal shifts.
引用
收藏
页码:865 / 875
页数:11
相关论文
共 31 条
  • [1] Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non-Small-Cell Lung Cancer
    Auperin, Anne
    Le Pechoux, Cecile
    Rolland, Estelle
    Curran, Walter J.
    Furuse, Kiyoyuki
    Fournel, Pierre
    Belderbos, Jose
    Clamon, Gerald
    Ulutin, Hakki Cuneyt
    Paulus, Rebecca
    Yamanaka, Takeharu
    Bozonnat, Marie-Cecile
    Uitterhoeve, Apollonia
    Wang, Xiaofei
    Stewart, Lesley
    Arriagada, Rodrigo
    Burdett, Sarah
    Pignon, Jean-Pierre
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) : 2181 - 2190
  • [2] Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
    Bahadoer, Renu R.
    Dijkstra, Esmee A.
    van Etten, Boudewijn
    Marijnen, Corrie A. M.
    Putter, Hein
    Kranenbarg, Elma Meershoek-Klein
    Roodvoets, Annet G. H.
    Nagtegaal, Iris D.
    Beets-Tan, Regina G. H.
    Blomqvist, Lennart K.
    Fokstuen, Tone
    ten Tije, Albert J.
    Capdevila, Jaume
    Hendriks, Mathijs P.
    Edhemovic, Ibrahim
    Cervantes, Andres
    Nilsson, Per J.
    Glimelius, Bengt
    van de Velde, Cornelis J. H.
    Hospers, Geke A. P.
    [J]. LANCET ONCOLOGY, 2021, 22 (01) : 29 - 42
  • [3] Radiotherapy in small countries
    Barton, Michael B.
    Zubizarreta, Eduardo H.
    Rubio, J. Alfredo Polo
    [J]. CANCER EPIDEMIOLOGY, 2017, 50 : 257 - 259
  • [4] Estimating the demand for radiotherapy from the evidence: A review of changes from 2003 to 2012
    Barton, Michael B.
    Jacob, Susannah
    Shafiq, Jesmin
    Wong, Karen
    Thompson, Stephen R.
    Hanna, Timothy P.
    Delaney, Geoff P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 112 (01) : 140 - 144
  • [5] Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project
    Bentzen, SM
    Heeren, G
    Cottier, B
    Slotman, B
    Glimelius, B
    Lievens, Y
    van den Bogaert, W
    [J]. RADIOTHERAPY AND ONCOLOGY, 2005, 75 (03) : 355 - 365
  • [6] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
    Bonner, JA
    Harari, PM
    Giralt, J
    Azarnia, N
    Shin, DM
    Cohen, RB
    Jones, CU
    Sur, R
    Raben, D
    Jassem, J
    Ove, R
    Kies, MS
    Baselga, J
    Youssoufian, H
    Amellal, N
    Rowinsky, EK
    Ang, KK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) : 567 - 578
  • [7] How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis
    Borras, Josep M.
    Lievens, Yolande
    Barton, Michael
    Corral, Julieta
    Ferlay, Jacques
    Bray, Freddie
    Grau, Cai
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 (01) : 5 - 11
  • [8] Budach W, 2011, STRAHLENTHER ONKOL, V187, P449, DOI 10.1007/s00066-011-2273-z
  • [9] Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
    Conroy, Thierry
    Bosset, Jean-Francois
    Etienne, Pierre-Luc
    Rio, Emmanuel
    Francois, Eric
    Mesgouez-Nebout, Nathalie
    Vendrely, Veronique
    Artignan, Xavier
    Bouche, Olivier
    Gargot, Dany
    Boige, Valerie
    Bonichon-Lamichhane, Nathalie
    Louvet, Christophe
    Morand, Clotilde
    de la Fouchardiere, Christelle
    Lamfichekh, Najib
    Juzyna, Beata
    Jouffroy-Zeller, Claire
    Rullier, Eric
    Marchal, Frederic
    Gourgou, Sophie
    Castan, Florence
    Borg, Christophe
    [J]. LANCET ONCOLOGY, 2021, 22 (05) : 702 - 715
  • [10] Radiotherapy infrastructure and human resources in Europe - Present status and its implications for 2020
    Datta, Niloy Ranjan
    Samiei, Massoud
    Bodis, Stephan
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (15) : 2735 - 2743